BioCentury
ARTICLE | Finance

Trailing indicator

December 4, 2000 8:00 AM UTC

Biotech somehow still is managing to avoid the hammering put on the broader NASDAQ market. Although the BioCentury 100 is down 4 percent over the last two weeks and stands down 19 percent since the Nov. 7 U.S. presidential election, the NASDAQ Composite has fared worse, tumbling 13 percent over the last two weeks and off 23 percent since the election.

Encouraging trends were seen on Friday, as technology bargain-hunters drove the BioCentury 100 up 4.3 percent on the day...